Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda,...(tacts: Ruder Finn Israel for Oramed ....),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
Date:11/4/2008
tacts:
Ruder Finn Israel for Oramed
Matthew Krieger
Cell: +972-54-467-6950
Office: +972-2-589-2003
Email: matthew@oramed.com
'/>"/>
| SOURCE Oramed Pharmaceticals Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
2. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
3. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
8. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
9. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
10. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
11. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
Post Your Comments:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4New Study of House Health Reform Bill 3A Iowa Faces Over 24348 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55160 1New Study of House Health Reform Bill 3A Iowa Faces Over 24348 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55160 2First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 1First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 2First Swedish Patients Receive MitraClip 28R 29 Therapy 55158 3Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT CRT Trial 13668 1Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT CRT Trial 13668 2
Other Medicine Technology:Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 2Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 3Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR,Annual Meeting Late-Breaking Clinical Trials Session 2Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR,Annual Meeting Late-Breaking Clinical Trials Session 3Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR,Annual Meeting Late-Breaking Clinical Trials Session 4Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR,Annual Meeting Late-Breaking Clinical Trials Session 5
Breaking Medicine News(10 mins):Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Study highlights lack of patient knowledge regarding hospital medications 2Health News:Nonprofit Partners With PR Company and Gains International Attention 2
[0] Nutraceutical Reports Fiscal 2009 Year End Results[0] Algeos Launches UK's First Private Podiatrist Loyalty Program[0] Study highlights lack of patient knowledge regarding hospital medications[0] Nonprofit Partners With PR Company and Gains International Attention[1] Amilpar - Relevant Fact - Public Offer
Other Medicine News:Health News:GNC Golf Outing Supports Local Charity, Injured Military 2Health News:CDC Reports High HIV Infection Rates in Communities of Color, Men Who Have Sex With Men 2Health News:CDC Reports High HIV Infection Rates in Communities of Color, Men Who Have Sex With Men 3Health News:Hurricane Ike: World Vision Readies Supplies, Staff, Volunteers for Response 2Health News:Palliative Care Programs Could Boost Hospitals' Bottom Line 2Health News:Weight-Loss Surgery Weighed as Diabetes Rx 2Health News:Weight-Loss Surgery Weighed as Diabetes Rx 3Health News:Weight-Loss Surgery Weighed as Diabetes Rx 4
GNC Golf Outing Supports Local Charity, Injured MilitaryCDC Reports High HIV Infection Rates in Communities of Color, Men Who Have Sex With MenHurricane Ike: World Vision Readies Supplies, Staff, Volunteers for ResponsePalliative Care Programs Could Boost Hospitals' Bottom Line Weight-Loss Surgery Weighed as Diabetes RxAbbott Declares 339th Consecutive Quarterly Dividend
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |